Merck’s Phase III KEYNOTE-B96 trial shows significant overall and progression-free survival gains with Keytruda plus ...

The KEYNOTE-B96 study of pembrolizumab plus paclitaxel in recurrent platinum-resistant ovarian cancer has met its primary end ...

Precision Oncology market is set for strong growth through 2035, fueled by genomic advances, rising cancer cases, and increased use of targeted therapies.

Medically reviewed by Mallory Christopherson DC, FMT, CSCS Many people try to relieve neck tension by forcefully twisting ...

Connor Edwards, 30, was once a life insurance salesmen who had a normal life but everything changed after he was bitten by a ...

Jodhpur: Granting relief, the Rajasthan High Court recently quashed the FIR against doctors booked for medical negligence ...